Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Rapid Whole Genome Sequencing Detects Microorganisms from Clinical Samples

By LabMedica International staff writers
Posted on 23 Dec 2013
A technique known as whole genome sequencing (WGS) has been used to identify and completely characterize bacteria causing urinary tract infections.

Application of this technology will help patients heal more quickly and avoid unnecessarily prolonged illness, help prevent outbreaks of hospital-acquired disease, and identify emerging infections. More...


Scientists at the Danish Technical University (Lyngby, Denmark) evaluated the applicability of WGS directly on clinical samples and developed easy-to-use bioinformatics tools for analysis of the sequenced data. They examined 35 random urine samples from patients with suspected urinary tract infections using conventional microbiology, WGS of isolated bacteria, and by directly sequencing on pellets from the urine. The 129 isolates were sequenced on the Ion Torrent Personal Genome Machine (PGM) (Life Technologies; Carlsbad, CA, USA).

Complete agreement was observed between species identification, multilocus-sequence typing, and phylogenetic relationship for the Escherichia coli and Enterococcus faecalis isolates when comparing the results of WGS of cultured isolates directly from urine samples. The investigators also identified bacteria in the patient samples that they did not detect using conventional techniques. Lactobacillus iners, Gardnerella vaginalis, Prevotella, and Aerococcus urinae have all been implicated in urinary tract infections, even though their precise roles as pathogens and normal colonizers of the genital tract have not been firmly established. They noted that by conventional methods A. urinae is rarely identified but frequently misclassified.

Sequencing directly from the urine enabled bacterial identification in polymicrobic samples and additional putative pathogenic strains were observed in some culture negative samples. This technique allowed the scientists in just 18 hours, to identify the microorganisms, characterized the pathogens' patterns of antibiotic susceptibility, and identified specific strains.

Frank M. Aarestrup, DVM, PhD, the senior author of the study said, “Using conventional methodologies this would have taken several days to weeks, and even using whole genome sequencing on cultured bacteria would have taken an extra day. Rapid identification of the causative agent and of any antibiotic resistance is crucial to choosing the correct treatment for individual patients. Choosing the wrong antibiotic will lead to longer infections and in the worst case, deaths.” The study was published online on October 10, 2013, in the Journal of Clinical Microbiology.

Related Links:

Danish Technical University
Life Technologies 



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.